Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging

Journal of Alzheimer's Disease

Volumn 47, Issue 4, 2015, Pages 889-899

  Solfrizzi, Vincenzo ^a,i   Panza, Francesco ^a,b   Imbimbo, Bruno P ^c   D'Introno, Alessia ^a   Galluzzo, Lucia ^d   Gandin, Claudia ^d   Misciagna, Giovanni ^e   Guerra, Vito ^e   Osella, Alberto ^e   Baldereschi, Marzia ^f   Di Carlo, Antonio ^f   Inzitari, Domenico ^g   Seripa, Davide ^b   Pilotto, Alberto ^b,h   Sabbá, Carlo ^a   Logroscino, Giancarlo ^a   Scafato, Emanuele ^d  

^a UNIVERSITY OF BARI   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c CHIESI FARMACEUTICI S P A   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^f CNR   (Italy)

^g UNIVERSITY OF FLORENCE   (Italy)

^h GALLIERA HOSPITAL   (Italy)

ⁱ POLICLINICO   (Italy)

Author keywords

Alzheimer's disease; Caffeine use; Coffee consumption; Dementia; Mild cognitive impairment

Indexed keywords

AGE DISTRIBUTION; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; CHILD; COFFEE; COGNITION; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; ITALIAN (CITIZEN); LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; SEX DIFFERENCE; DEPRESSION; FEEDING BEHAVIOR; ITALY; NEUROPSYCHOLOGICAL TEST; RISK; TEA; VERY ELDERLY;

CAFFEINE; COFFEE; TEA;

AGED; AGED, 80 AND OVER; AGING; CAFFEINE; COFFEE; DEPRESSION; FOLLOW-UP STUDIES; FOOD HABITS; HUMANS; ITALY; LONGITUDINAL STUDIES; MEN; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; RISK; SEX FACTORS; TEA; WOMEN;

EID: 84939438686     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-150333     Document Type: Article

References (62)

1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308.
2. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
3. Panza F, Solfrizzi V, Barulli MR, Bonfiglio C, Guerra V, Osella A, Seripa D, Sabbà C, Pilotto A, Logroscino G (2015) Coffee, tea, and caffeine consumption and prevention of latelife cognitive decline and dementia: A systematic review. J Nutr Health Aging 19, 313-328.
4. Lammi UK, Kivela SL, Nissinen A, Lammi UK, Kivela SL, Nissinen A (1989) Mental disability among elderly men in Finland: Prevalence, predictors and correlates. Acta Psychiatr Scand 80, 459-468.
5. Jarvis MJ (1993) Does caffeine intake enhance absolute levels of cognitive performance. Psychopharmacology (Berl) 110, 45-52.
6. Maia L, de Mendonca A (2002) Does caffeine intake protect from Alzheimer's disease? Eur J Neurol 9, 377-382.
7. Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, McDowell I (2002) Risk factors for Alzheimer's disease: A prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156, 445-453.
8. Johnson-Kozlow M, Kritz-Silverstein D, Barrett-Connor E, Morton D (2002) Coffee consumption and cognitive function among older adults. Am J Epidemiol 156, 842-850.
9. Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, Ebihara S,Awata S, Nagatomi R, Arai H, Tsuji I (2006) Green tea consumption and cognitive function: A cross-sectional studyfromtheTsurugayaProject1. AmJClinNutr83,355-361.
10. Ritchie K, Carriere I, de Mendonca A, Kalmijn S, Giampaoli S, Nissinen A, Kromhout D (2007) The neuroprotective effects of caffeine: A prospective population study (the Three City Study). Neurology 69, 536-545.
11. van Gelder B, Buijsse B, Tijhuis M, Kalmijn S, Giampaoli S, Nissinen A, Kromhout D (2007) Coffee consumption is inversely associated with cognitive decline in elderly European men: The FINE Study. Eur J Clin Nutr 61, 226-232.
12. Ng TP, Feng L, Niti M,Kua EH,YapKB(2008) Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr 88, 224-231.
13. Chin AV, Robinson DJ, O'Connell H, Hamilton F, Bruce I, Coen R,Walsh B, Coakley D, Molloy A, Scott J, Lawlor BA, Cunningham CJ (2008) Vascular biomarkers of cognitive performance in a community-based elderly population: The Dublin Healthy Ageing study. Age Ageing 37, 559-564.
14. Nurk E, Refsum H, Drevon CA, Tell GS, Nygaard HA, Engedal K, Smith AD (2009) Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. J Nutr 139, 120-127.
15. Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M (2009) Midlife coffee and tea drinking and the risk of late-life dementia: A population-based CAIDE study. J Alzheimers Dis 16, 85-91.
16. Santos C, Lunet N, Azevedo A, de Mendonca A, Ritchie K, Barros H (2010) Caffeine intake is associated with a lower risk of cognitive decline: A cohort study from Portugal. J Alzheimers Dis 20(Suppl 1), S175-S185.
17. Corley J, Jia X, Kyle JA, Gow AJ, Brett CE, Starr JM, McNeill G, Deary IJ (2010) Caffeine consumption and cognitive function at age 70: The Lothian Birth Cohort 1936 Study. Psychosom Med 72, 206-214.
18. Arab L, Biggs ML, O'Meara ES, Longstreth WT, Crane PK, Fitzpatrick AL (2011) Gender differences in tea, coffee, and cognitive decline in the elderly: The Cardiovascular Health Study. J Alzheimers Dis 27, 553-566.
19. Wu MS, Lan TH, Chen CM, Chiu HC, Lan TY (2011) Socio-demographic and health-related factors associated with cognitive impairment in the elderly in Taiwan. BMC Public Health 11, 22.
20. Vercambre MN, Berr C, Ritchie K, Kang JH (2013) Caffeine and cognitive decline in elderly women at high vascular risk. J Alzheimers Dis 35, 413-421.
21. Cao C, Loewenstein DA, Lin X, Zhang C, Wang L, Duara R, Wu Y, Giannini A, Bai G, Cai J, Greig M, Schofield E, Ashok R, Small B, Potter H, Arendash GW (2012) High Blood caffeine levels in MCI linked to lack of progression to dementia. J Alzheimers Dis 30, 559-572.
22. Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF, LongleyW, Anthony JC (1990) A case-control study of Alzheimer's disease in Australia. Neurology 40, 1698-1707.
23. Tyas SL, Manfreda J, Strain LA, Montgomery PR (2001) Risk factors for Alzheimer's disease: A population-based, longitudinal study in Manitoba, Canada. Int J Epidemiol 30, 590-597.
24. van Boxtel MP, Schmitt JA, Bosma H, Jolles J (2003) The effects of habitual caffeine use on cognitive change: A longitudinal perspective. Pharmacol Biochem Behav 75, 921-927.
25. Laurin D, Masaki KH, Foley DJ, White LR, Launer LJ (2004) Midlife dietary intake of antioxidants and risk of late-life incident dementia: The Honolulu-Asia Aging Study. Am J Epidemiol 159, 959-967.
26. Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB (2006) Fruit and vegetable juices and Alzheimer's disease: The Kame Project. Am J Med 119, 751-759.
27. Laitala V, Kaprio J, Koskenvuo M, Räihä I, Rinne JO, Silventoinen K (2009) Coffee drinking in middle age is not associated with cognitive performance in old age. Am J Clin Nutr 90, 640-646.
28. Gelber RP, Petrovitch H, Masaki KH, Abbott RD, Ross GW, Launer LJ, White LR (2011) Coffee intake in midlife and risk of dementia and its neuropathologic correlates. J Alzheimers Dis 23, 607-615.
29. Mirza SS, Tiemeier H, de Bruijn RF, Hofman A, Franco OH, Kiefte-de Jong J, Koudstaal PJ, Ikram MA (2014) Coffee consumption and incident dementia. Eur J Epidemiol 29, 735-741.
30. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, Initiative STROBE (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ 335, 806-808.
31. Solfrizzi V, Panza F, Colacicco AM, D'Introno A, Capurso C, Torres F, Grigoletto F, Maggi S, Del Parigi A, Reiman EM, Caselli RJ, Scafato E, Farchi G, Capurso A, Italian Longitudinal Study on Aging Working, Group (2004) Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 63, 1882-1891.
32. Folstein MF, Folstein SE, McHugh PR (1975) "Minimental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
33. Spinnler H, Tognoni G (1987) Standardizzazione e taratura italiana di test neuropsicologici. Italian J Neurol Sci 6(Suppl 8), 12-120.
34. Katz S, Akpom CA (1976) A measure of primary sociobiological functions. Int J Health Serv 6, 493-507.
35. Lawton MP, Brody EM (1969) Assessment of older people: Self maintaining and instrumental activities of daily living. Gerontologist 9, 179-186.
36. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, AdeyM, Leirer VO (1982-1983) Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 17, 37-49.
37. Solfrizzi V, Panza F, Colacicco AM, Capurso C, D'Introno A, Torres F, Baldassarre G, Capurso A (2002) Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > or =65 years of age (The Italian Longitudinal Study on Aging). Am J Cardiol 89, 825-829.
38. American Psychiatric Association Committee on Nomenclature and Statistics (1987) Diagnostic and statistical manual of mental disorders, 3rd ed. revised (DSM-III-R). American Psychiatric Association, Washington, DC, pp. 103-107.
39. McKhann G, Drachman D, Folstein M, McKhann G, Drachman D, Folstein M (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDSADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944.
40. World Health, Organization (1992) International statistical classification of diseases and related health problems, 10th revision (ICD-10). Chapter V, categories F00-F99. Mental, behavioural, and developmental disorders, clinical description and diagnostic guidelines, World Health Organization, Geneva.
41. Leoci CL, Centonze S, Guerra V, Cisternino AM, Misciagna G (1993) Validazione e riproducibilità di un questionario di frequenza alimentare semi-quantitativo autosomministrato. Giorn It Nutr Clin Prev 1, 58-59.
42. Solfrizzi V, Panza F, Torres F, Mastroianni F, Del Parigi A, Venezia A, Capurso A (1999) High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology 52, 1563-1569.
43. Crippa A, Discacciati A, Larsson SC,Wolk A, OrsiniN(2014) Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: A dose-response meta-analysis. Am J Epidemiol 180, 763-775.
44. Zhao Y, Wu K, Zheng J, Zuo R, Li D (2015) Association of coffee drinking with all-cause mortality: A systematic review and meta-analysis. Public Health Nutr 18, 1282-1291.
45. Barranco Quintana JL, Allam MF, Serrano Del Castillo A, Fernandez-Crehuet Navajas R (2007) Alzheimer's disease and coffee: A quantitative review. Neurol Res 29, 91-95.
46. Santos C, Costa J, Santos J, Vaz-Carneiro A, Lunet N (2010) Caffeine intake and dementia: Systematic review and metaanalysis. J Alzheimers Dis 20(Suppl 1), S187-S204.
47. Arab L, Khan F, Lam H (2013) Epidemiologic evidence of a relationship between tea, coffee, or caffeine consumption and cognitive decline. Adv Nutr 4, 115-122.
48. Dall'Igna OP, Fett P, GomesMW, Souza DO, Cunha RA, Lara DR(2007) Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice. Exp Neurol 203, 241-245.
49. Costenla AR, Cunha RA, de Mendonca A (2010) Caffeine, adenosine receptors, and synaptic plasticity. J Alzheimers Dis 20(Suppl 1), S25-S34.
50. Cao C, Cirrito JR, Lin X, Wang L, Verges DK, Dickson A, Mamcarz M, Zhang C, Mori T, ArendashGW, Holtzman DM, Potter H (2009) Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice. J Alzheimers Dis 17, 681-697.
51. Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H (2009) Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. J Alzheimers Dis 17, 661-680.
52. Ohno M, Watanabe S (1996) Working memory failure by stimulation of hippocampal adenosine A1 receptors in rats. Neuroreport 7, 3013-3016.
53. Pereira GS, Rossato JI, Sarkis JJ, Cammarota M, Bonan CD, Izquierdo I (2005) Activation of adenosine receptors in the posterior cingulate cortex impairs memory retrieval in the rat. Neurobiol Learn Mem 83, 217-223.
54. Pagnussat N, Almeida AS, Marques DM, Nunes F, Chenet GC, Botton PH, Mioranzza S, Loss CM, Cunha RA, Porcíuncula LO (2015) Adenosine A2A receptors are necessary and sufficient to trigger memory impairment in adult mice. Br J Pharmacol, doi: 10. 1111/bph. 13180
55. Li P, Rial D, Canas PM, Yoo JH, LiW, Zhou X,Wang Y, van Westen GJ, Payen MP, Augusto E, Goncalves N, Tomé AR, Li Z,Wu Z, Hou X, Zhou Y, Pijzerman A, Boyden ES, Cunha RA, Qu J, Chen JF (2015) Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory. Mol Psychiatry. doi: 10. 1038/mp. 2014. 182
56. Prediger RD, Batista LC, Takahashi RN (2005) Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats. Involvement of adenosine A1 and A2A receptors. Neurobiol Aging 26, 957-964.
57. Dall'Igna OP, Fett P, Gomes MW, Souza DO, Cunha RA, Lara DR (2007) Caffeine and adenosine A2A receptor antagonists prevent beta-amyloid 25-35-induced cognitive deficits in mice. Exp Neurol 203, 241-245.
58. Cornelis MC, El-Sohemy A, Campos H (2007) Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption. Am J Clin Nutr 86, 240-244.
59. Ritchie K, Artero S, Portet F, Brickman A, Muraskin J, Beanino E, Ancelin ML, Carrière I (2010) Caffeine, cognitive functioning, and white matter lesions in the elderly: Establishing causality from epidemiological evidence. J Alzheimers Dis 20(Suppl 1), S161-S166.
60. Biessels GJ (2010) Caffeine, diabetes, cognition, and dementia. J Alzheimers Dis 20(Suppl 1), S143-S150.
61. Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M, Koenig W, Sundvall J, Bidel S, Kuha S, Tuomilehto J (2010) Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: A clinical trial. Am J Clin Nutr 91, 950-957.
62. Abreu RV, Silva-Oliveira EM, Moraes MF, Pereira GS, Moraes-Santos T (2011) Chronic coffee and caffeine ingestion effects on the cognitive function and antioxidant system of rat brains. Pharmacol Biochem Behav 99, 659-664.